CP 544326,
CP-544326,
CP544326,
Taprenepag,
752187-80-7,
CP-544326,
CP544326,
CP 544326,
UNII-9CD894KUMJ,
9CD894KUMJ,
PF 04217329,
Taprenepagum,
Taprenepag [USAN:INN],
Taprenepag (USAN/INN),
Taprenepag(CP-544326),
GTPL5816,
SCHEMBL3318549,
CHEMBL2107783,
KS-00000TTV,
DTXSID00226187,
EX-A941,
BCP17228,
BCP24232,
BDBM50016953,
MFCD18633300,
ZINC72266311,
AKOS030632799,
API0013863,
CS-5590,
DB12623,
AK547949,
HY-14899,
D09968,
J-690347,
CP-544326;CP544326;CP 544326,
2-[3-[[(4-pyrazol-1-ylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid,
2-(3-((((4-(1H-pyrazol-1-yl)phenyl)methyl)(pyridin-3-ylsulfonyl)amino) methyl)phenoxy)acetic acid,
acetic acid, [3-[[[[4-(1H-pyrazol-1-yl)phenyl]methyl](3-pyridinylsulfonyl)amino]methyl]phenoxy]-,
Acetic acid, 2-(3-((((4-(1H-pyrazol-1-yl)phenyl)methyl)(3-pyridinylsulfonyl)amino) methyl)phenoxy)-,
TAPRENEPAG ISOPROPYL,
D0Y3LL,
PF-04217329,
PF-4217329,
A15853,
1,6-Dimethyl-3-[4-(trifluoromethyl)phenyl]pyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione,